Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung- cancers

Cancer Research

Volumn 59, Issue 22, 1999, Pages 5683-5686

  Lee, Sug Hyung ^a   Shin, Min Sun ^a   Kim, Hong Sug ^a   Lee, Hun Kyung ^a   Park, Won Sang ^a   Kim, Su Young ^a   Lee, Jong Heun ^a   Han, Seo Young ^a   Park, Jik Young ^a   Oh, Ro Ra ^a   Jang, Ja June ^b   Han, Ji Youn ^a   Lee, Jung Young ^a   Yoo, Nam Jin ^a  

^a The Catholic University of Korea   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; TUMOR NECROSIS FACTOR;

ALLELE; ARTICLE; CELL DEATH; CHROMOSOME 8P; CHROMOSOME LOSS; CONTROLLED STUDY; DELETION MUTANT; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION;

ADENOCARCINOMA; AMINO ACID SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 8; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; MUTATION, MISSENSE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0001130662     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Nagata, S. Apoptosis by death factor. Cell, 88: 355-365, 1997.
2. Griffith, T. S., and Lynch, D. L. TRAIL: a molecule with multiple receptors and control mechanisms. Curr. Opin. Immunol., 10: 559-563, 1998.
3. MacFarlane, M., Ahmad, M., Srinivasula, S. M., Fernades-Alnemri, T., Cohen, G. M., and Alnemri, E. S. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem., 272: 25417-25420, 1997.
4. Schneider, P., Thome, M., Bums, K., Bodmer, J-L., Hofmann, K., Kataoka, T., Holler, N., and Tschopp, J. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity, 7: 831-836, 1997.
5. Zhang, X. D., Franco, A., Myers, K., Gray, C., Nguyen, T., and Hersey, P. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Cancer Res., 59: 2747-2753, 1999.
6. Thomas, W. D., and Mersey, P. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 cell killing of target cells. J. Immunol., 161: 2195-2120, 1998.
7. Griffith, T. S., Chin, W. A., Jackson, G. C., Lynch, D. H., and Kubin, M. Z. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J. Immunol., 161: 2833-2840, 1998.
8. Keane, M. M., Ettenberg, S. A., Nau, M. M., Russell, E. K., and Lipkowitz, S. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res., 59: 734-741, 1999.
9. Mon, S., Murakami-Mori, K., Nakamura, S., Ashkenazi, A., and Bonavida, B. Sensitizalion of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D. J. Immunol., 162: 5616-5623, 1999.
10. Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C. L., Baker, K., Wood, W. I., Goddard, A. D., Godowski, P., and Ashkenazi, A. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science (Washington DC), 277: 818-821, 1997.
11. Pai, S. I., Wu, G. S., Ozoren, N., Wu, L., Jen, J., Sidransky, D., and El-Deiry, W. S. Rare loss-of-function mutation of a death receptor gene in head and neck cancer. Cancer Res., 58: 3513-3518, 1998.
12. Lee, S. H., Shin, M. S., Park, W. S., Kim, S. Y., Dong, S. M., Pi, J. H., Lee, H. K., Kim, H. S., Jang, J. J., Kim, C. S., Kim, S. H., Lee, J. Y., and Yoo, N. J. Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder. Cancer Res., 59: 3068-3072, 1999.
13. Lee, S. H., Shin, M. S., Park, W. S., Kim, S. Y., Kim, H. S., Han, J. Y., Park, G. S., Dong, S. M., Pi, J. H., Kim, C. S., Kim, S. H., Lee, J. Y., and Yoo, N. J. Alterations of Fas (APO-1/CD95) gene in non-small cell lung cancer. Oncogene, 18: 3754-3760, 1999.
14. Wistuba, I. I., Behrens, C., Virmani, A. K., Milchgrub, S., Syed, S., Lam, S., Mackay, B., Minna, J. D., and Gazdar, A. F. Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res., 59: 1973-1979, 1999.
15. Lerebours, F., Olschwang, S., Thuille, B., Schmitz, A., Fouchet, P., Buecher, B., Martinet, N., Galateau, F., and Thomas, G. Fine deletion mapping of chromosome 8p in non-small-cell lung carcinoma. Int. J. Cancer, 81: 854-858, 1999.
16. El-Naggar, A. K., Coombes, M. M., Batsakis, J. G., Hong, W. K., Goepfert, H., and Kagan, J. Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma. Oncogene, 16: 2983-2987, 1998.
17. Kagan, J., Stein, J., Babaian, R. J., Joe, Y. S., Pisters, L. L., Glassman, A. B., von Eschenbach, A. C., and Troncoso, P. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes. Oncogene, 11: 2121-2126, 1995.
18. Yaremko, M. L., Kutza, C., Lyzak, J., Mick, R., Recant, W. M., and Westbrook, C. A. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer. Genes Chromosomes Cancer, 16: 189-195, 1996.
19. Emi, M., Fujiwara, Y., Nakajima, T., Tsuchiya, E., Tsuda, H., Hirohashi, S., Maeda, Y., Tsuruta, K., Miyaki, M., and Nakamura, Y. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res., 52: 5368-5372, 1992.
20. Lee, J. Y., Dong, S. M., Kim, S. Y., Yoo, N. J., Lee, S. H., and Park, W. S. A simple, precise and economical micro-dissection technique for analysis of genomic DNA from archival tissue sections. Vircbows Arch., 433: 305-309, 1998.
21. Arai, T., Akiyama, Y., Okabe, S., Saito, K., Iwai, T., and Yuasa, Y. Genomic organization and mutation analyses of the DR5/TRAIL receptor 2 gene in colorectal carcinomas. Cancer Lett., 133: 197-204, 1998.
22. Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., Smith, C., Smolak, P., Goodwin, R. G., Rauch, C. T., Schuh, J. C., and Lynch, D. H. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med., 5: 157-163, 1999.
23. Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., DeForge, L., Koumenis, I. L., Lewis, D., Harris, L., Bussiere, J., Koeppen, H., Shahrokh, Z., and Schwall, R. H. Safety and antitumor activity of recombinant soluble apo2 ligand. J. Clin. Investig., 104: 155-162, 1999.
24. Krawczak, M., Reiss, J., and Cooper, D. N. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: cause and consequences. Hum. Genet., 90: 41-54, 1992.
25. Fujiwara, Y., Ohata, H., Kuroki, T., Koyama, K., Tsuchiya, E., Monden, M., and Nakamura, Y. Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor β gene. Oncogene, 10: 891-895, 1995.
26. MacGrogan, D., Levy, A., Bova, G. S., Isaacs, W. B., and Bookstein, R. Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. Genomics, 35: 55-65, 1996.